Clinical Efficacy and Safety of Ceftriaxone in Surgical Prophylaxis: A Systematic Review and Meta-Analysis
Клиническая эффективность и безопасность цефтриаксона при хирургической профилактике: систематический обзор и метаанализ
2024-05-28
SCID: 54.1/38cjc6nn
Discuss with AI
antimicrobial safetyceftriaxone surgical prophylaxisrandomized controlled trialssurgical site infectionsystematic review and meta-analysis
Figures from the paper
Abstract (AI)
Introduction Adequate antimicrobial monitoring helps identify the changing pattern of infection prevention postoperatively. The review aims at assessing the efficacy and safety of prophylactic ceftriaxone in surgical site infection. Materials and Methods The review followed Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. A systematic search was conducted in PubMed, EMBASE, and CINAHL databases. Randomized control trials, published till December 2022 in English, studying only preoperative ceftriaxone, and focusing on general surgical procedures were included. Meta-analysis was done using review manager software. Results Of the 2961 articles, nine were included in the review. Elevated gram-positive (33%) and gram-negative (67%) isolates were observed from the surgical site post-prophylaxis. Surgical site infection was developed in 53 (3.41%) patients in the ceftriaxone group and 108 (6.9%) patients in the comparator groups [OR 0.47 (95% CI: 0.33-0.65), p <0.0001]. Adverse events were assessed in six studies, from which 111 (21.4%) and 163 (31.2%) patients in the intervention and comparator groups developed the same [RR: 0.56 (95% CI: 0.31-1.01), p=0.06]. An overall estimate of [MD: -1.12 (95%CI: -1.36 to -0.89), p<0.00001)] was obtained on assessing hospital stays in the included articles. Conclusion The evidence generated identified various microbial isolates from the infected sites. The drug assured its efficacy profile in surgical prophylaxis. More studies in general surgery can give a better conclusion about ceftriaxone prophylaxis.
Key Findings
1
A systematic review and meta-analysis included nine randomized controlled trials evaluating preoperative ceftriaxone for prophylaxis in general surgery.
2
Adverse events were numerically lower with ceftriaxone than comparators (21.4% versus 31.2%), but the difference was not statistically significant (RR 0.56, 95% CI 0.31–1.01; p=0.06).
3
Ceftriaxone was associated with shorter hospital stays, with a mean difference of −1.12 (95% CI −1.36 to −0.89; p<0.00001); further general-surgery studies are needed for stronger conclusions.
4
Postoperative infection isolates were predominantly gram-negative (67%), with gram-positive organisms accounting for 33%.
5
Surgical site infections occurred less frequently with ceftriaxone than comparators: 3.41% versus 6.9% (OR 0.47, 95% CI 0.33–0.65; p<0.0001).
Research Object
preoperative ceftriaxone prophylaxis in general surgical procedures
Research Subject
clinical efficacy and safety, including prevention of surgical site infection, adverse events, and hospital length of stay
Publication Details
Publication Date
2024-05-28
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest